The Use of Ultrasound-Guided Injections for Tendinopathies

  • John W. OrchardEmail author
  • Richard Saw
  • Lorenzo Masci
Sports Imaging (J Linklater, Section Editor)
Part of the following topical collections:
  1. Sports Imaging


Purpose of Review

The purpose of the study was to review the efficacy and safety of common ultrasound-guided injections for tendinopathy conditions. Corticosteroid injections have historically been the most common injection used for tendinopathy; however, there are an increasing number of injections including platelet-rich plasma, hyaluronan, polidocanol, botulinum toxin, and high volume saline injections.

Recent Findings

There is growing evidence that while corticosteroid injections for tendinopathies usually have short-term efficacy, they may result in medium-term harm, particularly for tennis elbow (lateral epicondylitis). Corticosteroid injections appear to have more clinical utility for tenosynovitis conditions. There is insufficient evidence regarding other injection options to make a broad recommendation in favour, although individual trials for certain tendons illustrate benefits for some of the non-corticosteroid options.


When considering the use of ultrasound-guided corticosteroid injections for tendinopathies, the risk of possible medium-term harm must be weighed up against any short-term efficacy. Other injection-based therapies may be appropriate in certain clinical situations; however, the evidence and clinical circumstances must be considered for the particular tendon and patient. Load-based rehabilitation remains the cornerstone of tendinopathy management.


Tendinopathy Tenosynovitis Ultrasound-guided Injection Corticosteroid Platelet-rich-plasma 


Compliance with Ethical Guidelines

Conflict of interest

John W. Orchard, Richard Saw, and Lorenzo Masci each declare no potential conflicts of interest.

Human and Animal Rights and Informed Consent

None of the images illustrated in this study were obtained from live patients where consent would have been required (either cadaver models or self-images of the authors were used for all Figures).


Recently published papers of particular interest have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Glyn J. The discovery and early use of cortisone. J R Soc Med. 1998;91:513–7.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Liew D. Therapeutic guidelines: rheumatology. Version 3. Aust Prescr. 2017;40(5):202.Google Scholar
  3. 3.
    Smidt N, Assendelft WJ, van der Windt DA, Hay EM, Buchbinder R, Bouter LM. Corticosteroid injections for lateral epicondylitis: a systematic review. Pain. 2002;96(1–2):23–40.CrossRefPubMedGoogle Scholar
  4. 4.
    Bisset L, Beller E, Jull G, Brooks P, Darnell R, Vicenzino B. Mobilisation with movement and exercise, corticosteroid injection, or wait and see for tennis elbow: randomised trial. BMJ. 2006;333(7575):939. Scholar
  5. 5.
    Coombes BK, Bisset L, Brooks P, Khan A, Vicenzino B. Effect of corticosteroid injection, physiotherapy, or both on clinical outcomes in patients with unilateral lateral epicondylalgia: a randomized controlled trial. JAMA. 2013;309(5):461–9. Scholar
  6. 6.
    Coombes BK, Connelly L, Bisset L, Vicenzino B. Economic evaluation favours physiotherapy but not corticosteroid injection as a first-line intervention for chronic lateral epicondylalgia: evidence from a randomised clinical trial. Br J Sports Med. 2016;50(22):1400–5. Scholar
  7. 7.
    Olaussen M, Holmedal O, Mdala I, Brage S, Lindbaek M. Corticosteroid or placebo injection combined with deep transverse friction massage, Mills manipulation, stretching and eccentric exercise for acute lateral epicondylitis: a randomised, controlled trial. BMC Musculoskelet Disord. 2015;16:122. Scholar
  8. 8.
    Smidt N, van der Windt DA, Assendelft WJ, Deville WL, Korthals-de Bos IB, Bouter LM. Corticosteroid injections, physiotherapy, or a wait-and-see policy for lateral epicondylitis: a randomised controlled trial. Lancet. 2002;359(9307):657–62. Scholar
  9. 9.
    Branson R, Naidu K, du Toit C, Rotstein AH, Kiss R, McMillan D, et al. Comparison of corticosteroid, autologous blood or sclerosant injections for chronic tennis elbow. J Sci Med Sport. 2017;20(6):528–33. Scholar
  10. 10.
    Tosun HB, Gumustas S, Agir I, Uludag A, Serbest S, Pepele D, et al. Comparison of the effects of sodium hyaluronate-chondroitin sulphate and corticosteroid in the treatment of lateral epicondylitis: a prospective randomized trial. J Orthop Sci. 2015;20(5):837–43. Scholar
  11. 11.
    Fitzpatrick J, Bulsara M, Zheng MH. The effectiveness of platelet-rich plasma in the treatment of tendinopathy: a meta-analysis of randomized controlled clinical trials. Am J Sports Med. 2017;45(1):226–33. Scholar
  12. 12.
    de Vos RJ, Windt J, Weir A. Strong evidence against platelet-rich plasma injections for chronic lateral epicondylar tendinopathy: a systematic review. Br J Sports Med. 2014;48(12):952–6. Scholar
  13. 13.
    Mishra AK, Skrepnik NV, Edwards SG, Jones GL, Sampson S, Vermillion DA, et al. Efficacy of platelet-rich plasma for chronic tennis elbow: a double-blind, prospective, multicenter, randomized controlled trial of 230 patients. Am J Sports Med. 2014;42(2):463–71. Scholar
  14. 14.
    Gosens T, Mishra AK. Editorial in response to the systematic review by de Vos et al: strong evidence against platelet-rich plasma injections for chronic lateral epicondylar tendinopathy: a systematic review. Br J Sports Med. 2014;48(12):945–6. Scholar
  15. 15.
    Dong W, Goost H, Lin XB, Burger C, Paul C, Wang ZL, et al. Injection therapies for lateral epicondylalgia: a systematic review and Bayesian network meta-analysis. Br J Sports Med. 2016;50(15):900–8. Scholar
  16. 16.
    Krogh TP, Bartels EM, Ellingsen T, Stengaard-Pedersen K, Buchbinder R, Fredberg U, et al. Comparative effectiveness of injection therapies in lateral epicondylitis: a systematic review and network meta-analysis of randomized controlled trials. Am J Sports Med. 2013;41(6):1435–46. Scholar
  17. 17.
    Gosens T, Peerbooms JC, van Laar W, den Oudsten BL. Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: a double-blind randomized controlled trial with 2-year follow-up. Am J Sports Med. 2011;39(6):1200–8. Scholar
  18. 18.
    Peerbooms JC, Sluimer J, Bruijn DJ, Gosens T. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. Am J Sports Med. 2010;38(2):255–62. Scholar
  19. 19.
    Chiavaras MM, Jacobson JA, Carlos R, Maida E, Bentley T, Simunovic N, et al. IMpact of Platelet Rich plasma OVer alternative therapies in patients with lateral Epicondylitis (IMPROVE): protocol for a multicenter randomized controlled study: a multicenter, randomized trial comparing autologous platelet-rich plasma, autologous whole blood, dry needle tendon fenestration, and physical therapy exercises alone on pain and quality of life in patients with lateral epicondylitis. Acad Radiol. 2014;21(9):1144–55. Scholar
  20. 20.
    Petrella RJ, Cogliano A, Decaria J, Mohamed N, Lee R. Management of Tennis Elbow with sodium hyaluronate periarticular injections. Sports Med Arthrosc Rehabilit Ther Technol. 2010;2:4. Scholar
  21. 21.
    Fogli M, Giordan N, Mazzoni G. Efficacy and safety of hyaluronic acid (500–730 kDa) Ultrasound-guided injections on painful tendinopathies: a prospective, open label, clinical study. Muscles Ligaments Tendons J. 2017;7(2):388–95. Scholar
  22. 22.
    Khan IU, Awan AS, Khan AS, Marwat I, Meraj M. Efficacy of a single-injection sodium hyaluronate treatment in lateral epicondylitis. J Ayub Med Coll Abbottabad. 2018;30(1):85–9.PubMedGoogle Scholar
  23. 23.
    Wong SM, Hui AC, Tong PY, Poon DW, Yu E, Wong LK. Treatment of lateral epicondylitis with botulinum toxin: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2005;143(11):793–7.CrossRefPubMedGoogle Scholar
  24. 24.
    Mattie R, Wong J, McCormick Z, Yu S, Saltychev M, Laimi K. Percutaneous needle tenotomy for the treatment of lateral epicondylitis: a systematic review of the literature. PM & R. 2017;9(6):603–11. Scholar
  25. 25.
    Orchard J, Kountouris A. The management of tennis elbow. BMJ. 2011;342:d2687. Scholar
  26. 26.
    Knutsen EJ, Calfee RP, Chen RE, Goldfarb CA, Park KW, Osei DA. Factors associated with failure of nonoperative treatment in lateral epicondylitis. Am J Sports Med. 2015;43(9):2133–7. Scholar
  27. 27.
    • Degen RM, Cancienne JM, Camp CL, Altchek DW, Dines JS, Werner BC. Three or more preoperative injections is the most significant risk factor for revision surgery after operative treatment of lateral epicondylitis: an analysis of 3863 patients. J Shoulder Elbow Surg. 2017;26(4):704–9. One of a few recent studies showing cortisone injection predicts failure of subsequent surgery (elbow), suspicious but hard to remove confounders.
  28. 28.
    Kroslak M, Murrell GAC. Surgical treatment of lateral epicondylitis: a prospective, randomized, double-blinded, placebo-controlled clinical trial. Am J Sports Med. 2018;46(5):1106–13. Scholar
  29. 29.
    Titchener AG, Booker SJ, Bhamber NS, Tambe AA, Clark DI. Corticosteroid and platelet-rich plasma injection therapy in tennis elbow (lateral epicondylalgia): a survey of current U.K. specialist practice and a call for clinical guidelines. Br J Sports Med. 2015;49(21):1410–3. Scholar
  30. 30.
    Niedermeier SR, Crouser N, Speeckaert A, Goyal KSA. Survey of fellowship-trained upper extremity surgeons on treatment of lateral epicondylitis. Hand. 2018. Scholar
  31. 31.
    • Vicenzino B, Britt H, Pollack AJ, Hall M, Bennell KL, Hunter DJ. No abatement of steroid injections for tennis elbow in Australian General Practice: a 15-year observational study with random general practitioner sampling. PLoS ONE. 2017;12(7):e0181631. Despite high quality evidence showing harm of cortisone injections these persist as common practice for tennis elbow treatment.
  32. 32.
    •• Mohamadi A, Chan JJ, Claessen FM, Ring D, Chen NC. Corticosteroid injections give small and transient pain relief in rotator cuff tendinosis: a meta-analysis. Clin Orthop Relat Res. 2017;475(1):232–43. A balanced review revealing benefits of corticosteroid for rotator cuff pain but with authors also cautioning that these may be overstated in clinical practice.
  33. 33.
    • Cook T, Minns Lowe C, Maybury M, Lewis JS. Are corticosteroid injections more beneficial than anaesthetic injections alone in the management of rotator cuff-related shoulder pain? A systematic review. Br J Sports Med. 2018;52(8):497–504. Review of high quality cortisone vs local only injections showing definite benefit of cortisone at under 8 weeks but also evidence of no medium term benefit.
  34. 34.
    Gill TK, Shanahan EM, Allison D, Alcorn D, Hill CL. Prevalence of abnormalities on shoulder MRI in symptomatic and asymptomatic older adults. Int J Rheum Dis. 2014;17(8):863–71. Scholar
  35. 35.
    Girish G, Lobo LG, Jacobson JA, Morag Y, Miller B, Jamadar DA. Ultrasound of the shoulder: asymptomatic findings in men. AJR Am J Roentgenol. 2011;197(4):W713–9. Scholar
  36. 36.
    Abate M, Schiavone C, Salini V. Sonographic evaluation of the shoulder in asymptomatic elderly subjects with diabetes. BMC Musculoskelet Disord. 2010;11:278. Scholar
  37. 37.
    Cole B, Lam P, Hackett L, Murrell GAC. Ultrasound-guided injections for supraspinatus tendinopathy: corticosteroid versus glucose prolotherapy: a randomized controlled clinical trial. Shoulder Elb. 2018;10(3):170–8. Scholar
  38. 38.
    Flores C, Balius R, Alvarez G, Buil MA, Varela L, Cano C, et al. Efficacy and tolerability of peritendinous hyaluronic acid in patients with supraspinatus tendinopathy: a multicenter, randomized, controlled trial. Sports Med. 2017;3(1):22. Scholar
  39. 39.
    Bloom JE, Rischin A, Johnston RV, Buchbinder R. Image-guided versus blind glucocorticoid injection for shoulder pain. Cochrane Database Syst Rev. 2012. Scholar
  40. 40.
    Morrisroe K, Nakayama A, Soon J, Arnold M, Barnsley L, Barrett C, et al. EVOLVE: the Australian Rheumatology Association’s ‘top five’ list of investigations and interventions doctors and patients should question. Intern Med J. 2018;48(2):135–43. Scholar
  41. 41.
    • Finnoff JT, Hall MM, Adams E, Berkoff D, Concoff AL, Dexter W et al. American Medical Society for Sports Medicine (AMSSM) position statement: interventional musculoskeletal ultrasound in sports medicine. Br J Sports Med. 2015;49(3):145–50. Recent narrative view of ultrasound-guided injections in general, not just tendinopathies.
  42. 42.
    Aly AR, Rajasekaran S, Ashworth N. Ultrasound-guided shoulder girdle injections are more accurate and more effective than landmark-guided injections: a systematic review and meta-analysis. Br J Sports Med. 2015;49(16):1042–9. Scholar
  43. 43.
    Daniels EW, Cole D, Jacobs B, Phillips SF. Existing evidence on ultrasound-guided injections in sports medicine. Orthop J Sports Med. 2018;6(2):2325967118756576. Scholar
  44. 44.
    •• Fawcett R, Grainger A, Robinson P, Jafari M, Rowbotham E. Ultrasound-guided subacromial-subdeltoid bursa corticosteroid injections: a study of short- and long-term outcomes. Clin Radiol. 2018. Study showing that rotator cuff tendon quality may be an important determining factor regarding the success or failure of subacromial cortisone injections.
  45. 45.
    Lee SW, Tiu T, Roberts J, Lee B, Bartels MN, Oh-Park M. Point-of-care ultrasonography findings and care use among patients undergoing ultrasound-guided shoulder injections. Am J Phys Med Rehabil. 2018;97(1):56–61. Scholar
  46. 46.
    • Traven S, Brinton D, Simpson K, Adkins Z, Althoff A, Palsis J et al. Shoulder injection prior to rotator cuff repair is associated with increased risk of subsequent surgery. AOSSM Spec Day; One of a few recent studies showing cortisone injection predicts failure of subsequent surgery (shoulder), abstract form publication only to date.
  47. 47.
    Suzuki K, Potts A, Anakwenze O, Singh A. Calcific tendinitis of the rotator cuff: management options. J Am Acad Orthop Surg. 2014;22(11):707–17. Scholar
  48. 48.
    Peters-Veluthamaningal C, van der Windt DA, Winters JC, Meyboom-de Jong B. Corticosteroid injection for de Quervain’s tenosynovitis. Cochrane Database Syst Rev. 2009. Scholar
  49. 49.
    Rowland P, Phelan N, Gardiner S, Linton KN, Galvin R. The effectiveness of corticosteroid injection for De Quervain’s stenosing tenosynovitis (DQST): a systematic review and meta-analysis. Open Orthop J. 2015;9:437–44. Scholar
  50. 50.
    Ashraf MO, Devadoss VG. Systematic review and meta-analysis on steroid injection therapy for de Quervain’s tenosynovitis in adults. Eur J Orthop Surg Traumatol. 2014;24(2):149–57. Scholar
  51. 51.
    • Cavaleri R, Schabrun SM, Te M, Chipchase LS. Hand therapy versus corticosteroid injections in the treatment of De Quervain’s disease: a systematic review and meta-analysis. J Hand Ther. 2016;29(1):3–11. Meta-analysis showing hand orthoses prescribed by therapist and cortisone injections for de Quervain’s tenosynovitis superior to either treatment option alone.
  52. 52.
    • Danda RS, Kamath J, Jayasheelan N, Kumar P. Role of guided ultrasound in the treatment of De Quervain Tenosynovitis by local steroid infiltration. J Hand Microsurg. 2016;8(1):34–7. Moderate level study suggesting that multiple injections of cortisone into different compartments may be more successful than single cortisone injection for De Quervain Tenosynovitis.
  53. 53.
    McDermott JD, Ilyas AM, Nazarian LN, Leinberry CF. Ultrasound-guided injections for de Quervain’s tenosynovitis. Clin Orthop Relat Res. 2012;470(7):1925–31. Scholar
  54. 54.
    Balakatounis K, Angoules AG, Angoules NA, Panagiotopoulou K. Synthesis of evidence for the treatment of intersection syndrome. World J Orthop. 2017;8(8):619–23. Scholar
  55. 55.
    Waryasz GR, Tambone R, Borenstein TR, Gil JA, DaSilva M. A Review of anatomical placement of corticosteroid injections for uncommon hand, wrist, and elbow pathologies. Rhode Island Med J. 2017;100(2):31–4.Google Scholar
  56. 56.
    Peters-Veluthamaningal C, van der Windt DA, Winters JC, Meyboom-de Jong B. Corticosteroid injection for trigger finger in adults. Cochrane Database Syst Rev. 2009. Scholar
  57. 57.
    •• Mellor R, Bennell K, Grimaldi A, Nicolson P, Kasza J, Hodges P et al. Education plus exercise versus corticosteroid injection use versus a wait and see approach on global outcome and pain from gluteal tendinopathy: prospective, single blinded, randomised clinical trial. BMJ. 2018;361:k1662. Corticosteroid did beat ‘wait and see’ in this study but both arms inferior to an education and exercise based arm in this high quality RCT.
  58. 58.
    • Fitzpatrick J, Bulsara MK, O’Donnell J, McCrory PR, Zheng MH. The effectiveness of platelet-rich plasma injections in gluteal tendinopathy: a randomized, double-blind controlled trial comparing a single platelet-rich plasma injection with a single corticosteroid injection. Am J Sports Med. 2018;46(4):933–9. PRP injection superior to cortisone in this study but no inactive (placebo) injection option and therefore hard to differentiate between assistance of PRP versus possible harm of cortisone.
  59. 59.
    Serner A, Tol JL, Jomaah N, Weir A, Whiteley R, Thorborg K, et al. Diagnosis of acute groin injuries: a prospective study of 110 athletes. Am J Sports Med. 2015;43(8):1857–64. Scholar
  60. 60.
    Nicholson LT, DiSegna S, Newman JS, Miller SL. Fluoroscopically guided peritendinous corticosteroid injection for proximal hamstring tendinopathy: a retrospective review. Orthop J Sports Med. 2014;2(3):2325967114526135. Scholar
  61. 61.
    Zissen MH, Wallace G, Stevens KJ, Fredericson M, Beaulieu CF. High hamstring tendinopathy: MRI and ultrasound imaging and therapeutic efficacy of percutaneous corticosteroid injection. AJR Am J Roentgenol. 2010;195(4):993–8. Scholar
  62. 62.
    Wetzel RJ, Patel RM, Terry MA. Platelet-rich plasma as an effective treatment for proximal hamstring injuries. Orthopedics. 2013;36(1):e64–70. Scholar
  63. 63.
    Ang TW. The effectiveness of corticosteroid injection in the treatment of plantar fasciitis. Singap Med J. 2015;56(8):423–32. Scholar
  64. 64.
    •• David JA, Sankarapandian V, Christopher PR, Chatterjee A, Macaden AS. Injected corticosteroids for treating plantar heel pain in adults. Cochrane Database Syst Rev. 2017;6:Cd009348. High quality systematic review but revealing low quality evidence in primary trials, generally showing some benefit of cortisone injection for up to 4 weeks in plantar fasciitis but not beyond.
  65. 65.
    McMillan AM, Landorf KB, Gilheany MF, Bird AR, Morrow AD, Menz HB. Ultrasound guided corticosteroid injection for plantar fasciitis: randomised controlled trial. BMJ. 2012;344:e3260. Scholar
  66. 66.
    • Yang WY, Han YH, Cao XW, Pan JK, Zeng LF, Lin JT et al. Platelet-rich plasma as a treatment for plantar fasciitis: a meta-analysis of randomized controlled trials. Medicine. 2017;96(44):e8475. No differences seen between PRP and cortisone for plantar fasciitis at 12 weeks or less, but some evidence of benefit favouring PRP at 24 weeks or more.
  67. 67.
    • Kearney RS, Parsons N, Metcalfe D, Costa ML. Injection therapies for Achilles tendinopathy. Cochrane Database Syst Rev. 2015(5):Cd010960. Important publication but concluding quality of evidence for almost all Achilles injection options is poor and very few conclusions can be made.
  68. 68.
    Chechick A, Amit Y, Israeli A, Horoszowski H. Recurrent rupture of the achilles tendon induced by corticosteroid injection. Br J Sports Med. 1982;16(2):89–90.CrossRefPubMedPubMedCentralGoogle Scholar
  69. 69.
    Claessen FM, de Vos RJ, Reijman M, Meuffels DE. Predictors of primary Achilles tendon ruptures. Sports Med. 2014;44(9):1241–59. Scholar
  70. 70.
    Kao NL, Moy JN, Richmond GW. Achilles tendon rupture: an underrated complication of corticosteroid treatment. Thorax. 1992;47(6):484.CrossRefPubMedPubMedCentralGoogle Scholar
  71. 71.
    Kok LM, Benard MR, van Arkel ER. Bilateral Achilles tendon rupture following levofloxacin and glucocorticoid use. Ned Tijdschr Geneeskd. 2012;156(13):A4192.PubMedGoogle Scholar
  72. 72.
    Mahler F, Fritschy D. Partial and complete ruptures of the Achilles tendon and local corticosteroid injections. Br J Sports Med. 1992;26(1):7–14.CrossRefPubMedPubMedCentralGoogle Scholar
  73. 73.
    Spoendlin J, Meier C, Jick SS, Meier CR. Oral and inhaled glucocorticoid use and risk of Achilles or biceps tendon rupture: a population-based case-control study. Ann Med. 2015;47(6):492–8. Scholar
  74. 74.
    Turmo-Garuz A, Rodas G, Balius R, Til L, Miguel-Perez M, Pedret C, et al. Can local corticosteroid injection in the retrocalcaneal bursa lead to rupture of the Achilles tendon and the medial head of the gastrocnemius muscle? Musculoskelet Surg. 2014;98(2):121–6. Scholar
  75. 75.
    Vallone G, Vittorio T. Complete Achilles tendon rupture after local infiltration of corticosteroids in the treatment of deep retrocalcaneal bursitis. J Ultrasound. 2014;17(2):165–7. Scholar
  76. 76.
    • Stenson JF, Reb CW, Daniel JN, Saini SS, Albana MF. Predicting failure of nonoperative treatment for insertional Achilles tendinosis. Foot Ankle Spec. 2018;11(3):252–5. One of a few recent studies showing cortisone injection predicts failure of subsequent surgery (Achilles), suspicious but hard to remove confounders.
  77. 77.
    Srivastava P, Aggarwal A. Ultrasound-guided retro-calcaneal bursa corticosteroid injection for refractory Achilles tendinitis in patients with seronegative spondyloarthropathy: efficacy and follow-up study. Rheumatol Int. 2016;36(6):875–80. Scholar
  78. 78.
    Danielson P, Andersson G, Alfredson H, Forsgrenn S. Marked sympathetic component in the perivascular innervation of the dorsal paratendinous tissue of the patellar tendon in arthroscopically treated tendinosis patients. Knee Surg Sports Traumatol Arthrosc. 2008;16(6):621–6.CrossRefPubMedGoogle Scholar
  79. 79.
    Andersson G, Danielson P, Alfredson H, Forsgren S. Nerve-related characteristics of ventral paratendinous tissue in chronic Achilles tendinosis. Knee Surg Sports Traumatol Arthrosc. 2007;15(10):1272–9.CrossRefPubMedGoogle Scholar
  80. 80.
    Willberg L, Sunding K, Ohberg L, Forssblad M, Fahlstrom M, Alfredson H. Sclerosing injections to treat midportion Achilles tendinosis: a randomised controlled study evaluating two different concentrations of Polidocanol. Knee Surg Sports Traumatol Arthrosc. 2008;16(9):859–64. Scholar
  81. 81.
    Hoksrud A, Bahr R. Ultrasound-guided sclerosing treatment in patients with patellar tendinopathy (jumper’s knee). 44-month follow-up. Am J Sports Med. 2011;39(11):2377–80. Scholar
  82. 82.
    Fenelon C, Galbraith JG, Hession P, D’Souza LG. Complete tendon Achilles rupture following injection of Aethoxysklerol (polidocanol) for the treatment of chronic Achilles tendinopathy. Foot and Ankle Surg. 2017;23(4):e7–8. Scholar
  83. 83.
    Kumai T, Muneta T, Tsuchiya A, Shiraishi M, Ishizaki Y, Sugimoto K, et al. The short-term effect after a single injection of high-molecular-weight hyaluronic acid in patients with enthesopathies (lateral epicondylitis, patellar tendinopathy, insertional Achilles tendinopathy, and plantar fasciitis): a preliminary study. J Orthop Sci. 2014;19(4):603–11. Scholar
  84. 84.
    Muneta T, Koga H, Ju YJ, Mochizuki T, Sekiya I. Hyaluronan injection therapy for athletic patients with patellar tendinopathy. J Orthop. Sci. 2012;17(4):425–31. Scholar
  85. 85.
    Gorelick L, Saab A. Single hyaluronate injection in the management of insertional achilles tendinopathy in comparison to corticosteroid injections and non-invasive conservative treatments. Scholars Bull. 2015;1(1):16–20.Google Scholar
  86. 86.
    • Boesen AP, Hansen R, Boesen MI, Malliaras P, Langberg H. Effect of high-volume injection, platelet-rich plasma, and sham treatment in chronic midportion Achilles tendinopathy: a randomized double-blinded prospective study. Am J Sports Med. 2017;45(9):2034–43. High volume injection including cortisone (particularly in the short-term) and PRP (over medium-term time-frame) superior to placebo injection for Achilles tendinopathy, but study likely to be at risk of bias due to clearly different injection regimes.
  87. 87.
    Chan O, O’Dowd D, Padhiar N, Morrissey D, King J, Jalan R, et al. High volume image guided injections in chronic Achilles tendinopathy. Disabil Rehabil. 2008;30(20–22):1697–708. Scholar
  88. 88.
    Humphrey J, Chan O, Crisp T, Padhiar N, Morrissey D, Twycross-Lewis R, et al. The short-term effects of high volume image guided injections in resistant non-insertional Achilles tendinopathy. J Sci Med Sport. 2010;13(3):295–8. Scholar
  89. 89.
    Maffulli N, Spiezia F, Longo UG, Denaro V, Maffulli GD. High volume image guided injections for the management of chronic tendinopathy of the main body of the Achilles tendon. Phys Ther Sport. 2013;14(3):163–7. Scholar
  90. 90.
    Wheeler PC, Mahadevan D, Bhatt R, Bhatia M. A comparison of two different high-volume image-guided injection procedures for patients with chronic noninsertional Achilles tendinopathy: a pragmatic retrospective cohort study. J Foot Ankle Surg. 2016;55(5):976–9. Scholar
  91. 91.
    Sanderson LM, Bryant A. Effectiveness and safety of prolotherapy injections for management of lower limb tendinopathy and fasciopathy: a systematic review. J Foot Ankle Res. 2015;8:57. Scholar
  92. 92.
    Coombes BK, Bisset L, Vicenzino B. Efficacy and safety of corticosteroid injections and other injections for management of tendinopathy: a systematic review of randomised controlled trials. Lancet. 2010;376(9754):1751–67. Scholar
  93. 93.
    Orchard J, Massey A, Brown R, Cardon-Dunbar A, Hofmann J. Successful management of tendinopathy with injections of the MMP-inhibitor aprotinin. Clin Orthop Relat Res. 2008;466(7):1625–32. Scholar
  94. 94.
    van Ark M, Zwerver J, van den Akker-Scheek I. Injection treatments for patellar tendinopathy. Br J Sports Med. 2011;45(13):1068–76. Scholar
  95. 95.
    Cirakli A, Gurgor PN, Uzun E, Erdem H, Cankaya S, Bas O. Local application of tranexamic acid affects tendon healing negatively in the late period. Joint Dis Relat Surg. 2018;29(1):20–6.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.School of Public HealthUniversity of SydneySydneyAustralia
  2. 2.Olympic Park Sports Medicine CentreMelbourneAustralia
  3. 3.Pure Sports Medicine ClinicLondonUK

Personalised recommendations